SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-16-000039
Filing Date
2016-08-09
Accepted
2016-08-09 08:11:18
Documents
52
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q q2201610-q.htm 10-Q 1021956
2 EXHIBIT 31.1 q22016exhibit311.htm EX-31.1 12537
3 EXHIBIT 31.2 q22016exhibit312.htm EX-31.2 12597
4 EXHIBIT 32.1 q22016exhibit321.htm EX-32.1 6823
5 EXHIBIT 32.2 q22016exhibit322.htm EX-32.2 6739
12 pipeline.jpg GRAPHIC 101452
  Complete submission text file 0001367920-16-000039.txt   4643561

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20160630.xml EX-101.INS 895628
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20160630.xsd EX-101.SCH 30411
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20160630_cal.xml EX-101.CAL 59191
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20160630_def.xml EX-101.DEF 144083
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20160630_lab.xml EX-101.LAB 430880
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20160630_pre.xml EX-101.PRE 265528
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 161816133
SIC: 2834 Pharmaceutical Preparations